Protein and antibody manufacturing is a core HGS competency. Our manufacturing capability represents a significant strategic advantage. We are able to produce and purify multiple protein and antibody drugs in two state-of-the-art cGMP-compliant process development and manufacturing facilities – totaling approximately 400,000 square feet and offering both small-scale and large-scale production.

Our manufacturing, quality, process development and engineering groups are fully integrated and have extensive experience and an established track record of efficient execution of cGMP manufacturing campaigns. We have successfully developed and implemented production processes using a variety of expression systems, and we are well prepared to support the production requirements of our clinical development programs and the commercial launch of our products.

Please click here for a brochure on HGS manufacturing capabilities